News provided by CVS Health May 28, 2026, 06:45 ET Expanded GLP-1 options for members create a path to sustainable coverage of these important medications WOONSOCKET, R.I., May 28, 2026 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced updates to its most common commercial formularies, expanding GLP-1 options for members including the reintroduction of Zepbound (tirzepatide) as a covered medication
(Try discount sites like TrumpRx or GoodRx.) Even with discounts, the drugs are not affordable for everyone
He turns his video camera around to show me the night sky above Abu Dhabi, where hes been watching Emirati defenses intercept Iranian missiles
To kill a cancer: Targeting the immune inhibitory checkpoint molecule, B7-H3
They are not typically prescribed for individuals with type 1 diabetes, as the mechanism of action primarily targets insulin secretion and glucose regulation in type 2 diabetes
This guide will help you explore your options to achieve that sought-after glow from within